Uses of Modified ELR-CXC Chemokine G31P To Treat Cancer
- 专利权人:
- John R. Gordon
- 发明人:
- John R. Gordon,Fang Li
- 申请号：
- US13048290
- 公开号：
- US20120070405A1
- 申请日:
- 2011.03.15
- 申请国别(地区):
- US
- 年份:
- 2012
- 代理人:
- 摘要：
- Described herein is the use of a modified human chemokine, GS-CXCL8(3-72)K11R/G31P or G31P in the treatment of a number of cancers, including but by no means limited to prostate cancer, liver cancer and melanoma.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Substituted lactones for treating cancer
- Pyrazolone compounds and their use
- COMPOSITIONS ET METHODES POUR LE TRAITEMENT D'UN CANCER
- COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT D'UN CANCER
- COMBINATION THERAPY USING C-C CHEMOKINE RECEPTOR 4 (CCR4) ANTAGONISTS AND ONE OR MORE IMMUNE CHECKPOINT INHIBITORS
